North Carolina CTSAs collaborate to help researchers navigate complex regulatory environment

May 10, 2018 CTSA Center for Leading Innovation & Collaboration

Three North Carolina Clinical and Translational Science Awards (CTSA) Program hubs have collaborated to create a platform for sharing regulatory expertise and best practices. The Regulatory Guidance for Academic Research of Drugs and Devices (ReGARDD) Program provides researchers with regulatory guidance, education, and consultative support, to ultimately help them move promising products and novel discoveries to clinical trials.

ReGARDD, which is coordinated by the hubs at Duke University, the Wake Forest School of Medicine, and the University of North Carolina at Chapel Hill (UNC-Chapel Hill) with partner RTI International, officially launched in 2015 and has been developing since. The program builds upon the existing services and knowledge of the North Carolina CTSA Program Regulatory Groups and the Research Triangle Park (RTP).

Read the full article on the CTSA CLIC website.

Learn more about the ReGARDD Program by visiting Related questions can be directed to Michelle Maclay, director of community and partner relations, NC TraCS Institute.